Commentary

Correction: The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML (Leukemia, (2019), 33, 11, (2628-2639), 10.1038/s41375-019-0581-y)

Citation

Kahl M, Brioli A, Bens M, Perner F, Kresinsky A, Schnetzke U, Hinze A, Sbirkov Y, Stengel S, Simonetti G, Martinelli G, Petrie K, Zelent A, Böhmer F & Groth M (2020) Correction: The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML (Leukemia, (2019), 33, 11, (2628-2639), 10.1038/s41375-019-0581-y). Commentary on: Kahl, M., Brioli, A., Bens, M. et al. The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML. Leukemia 33, 2628–2639 (2019). https://doi.org/10.1038/s41375-019-0581-y. Leukemia, 34, Art. No.: 1972. https://doi.org/10.1038/s41375-020-0706-3

Abstract
Since publication of the original article the authors noticed that affiliation 8Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy was presented incorrectly. This has now been corrected in the HTML and PDF versions of this article.

Notes
Additional co-authors: Thomas Ernst, Florian H. Heidel, Sebastian Scholl, Andreas Hochhaus & Tino Schenk

Journal
Leukemia: Volume 34

StatusPublished
Publication date31/12/2020
Publication date online16/01/2020
Date accepted by journal16/01/2020
ISSN0887-6924
Item discussedKahl, M., Brioli, A., Bens, M. et al. The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML. Leukemia 33, 2628–2639 (2019). https://doi.org/10.1038/s41375-019-0581-y